Proto Labs Inc

Protolabs announced on August 24 that Sam Ramahi will become its Chief Operations Officer, effective August 31, leading global operations, supply chain, quality, sourcing, and continuous improvement and reporting to President and CEO Suresh Krishna. Ramahi brings more than 25 years of operations leadership at global industrial companies, most recently as Vice President of North America Operations at SIG Group, where he oversaw a 1,300-person organization across five manufacturing facilities supporting $700 million in annual revenue, and previously served as Chief Operating Officer at Jacuzzi Group and in leadership posts at nVent, Eaton, Cooper Industries, Honeywell, and GE Healthcare. The hire follows a second quarter in which Protolabs reported revenue of $149.3 million, up 10.6% year over year, with CNC machining revenue growing 13.6% and injection molding revenue growing 13.1%, while GAAP gross margin rose to 46.4% from 44.3% a year earlier and the company raised its full-year 2026 revenue growth guidance from a range of 6% to 8% up to 8% to 10%. GAAP operating margin came in at 7.6% for the quarter, well below the 12.0% non-GAAP figure, and cash generated from operations was $15.4 million against $149.3 million in revenue. Hedge fund ownership of Protolabs rose from 28 funds to 30 in the most recent quarter, and short interest sits at 3.53% of float.

Proto Labs has appointed Sam Ramahi as Chief Operations Officer, effective August 31, 2026, to oversee global operations, supply chain, quality, sourcing, and continuous improvement under CEO Suresh Krishna's overall operational oversight. The company was also recognized by Business Insider as one of America's Most Innovative Businesses, backed by more than 120 patents and ongoing R&D investment. Ramahi's appointment aligns with Proto Labs' focus on scaling CNC and sheet metal production, while the launch of its AI-powered quoting platform, ProDesk, supports higher revenue per customer and cross-platform adoption. However, risks remain from pressure on legacy prototyping and injection molding services, as well as concentration in a few large Aerospace & Defense accounts. Proto Labs' narrative projects $697.6 million revenue and $58.5 million earnings by 2029, requiring 7.6% yearly revenue growth, with a fair value estimate of $95.50, representing a 17% upside to its current price.

Protolabs CEO Suresh Krishna says the company is well-positioned to benefit from the reshoring of manufacturing to the United States, even as the Trump administration considers additional semiconductor tariffs that could raise costs for imported data center equipment. Krishna noted that Protolabs serves all industries, including electronics customers like ASML, and is investing heavily to meet growing demand, with over $150 million in cash and more than $10 million invested this year in CNC machining, 3D printing, and injection molding equipment. He cited evidence of reshoring across rockets, satellites, data centers, drones, and medical devices, with clients including Medtronic, Johnson & Johnson, Boston Scientific, SpaceX, Blue Origin, Anduril, AeroVironment, and Skydio. Krishna emphasized that as manufacturing expands—the index has grown for six consecutive months—companies increasingly rely on Protolabs for supply chain resilience and capacity investment.

Proto Labs raised its full-year 2026 revenue growth guidance to 8%–10% and issued third-quarter guidance for revenue of US$145.0 million to US$153.0 million and GAAP diluted EPS of US$0.34 to US$0.42. The company reported second-quarter sales of US$149.34 million and net income of US$9.15 million, while management highlighted a 17% year-over-year increase in revenue per customer. Proto Labs also filed a US$29.68 million ESOP-related shelf registration for 395,000 common shares, underscoring deeper enterprise engagement and ongoing investment in its workforce.

Proto Labs posted record revenue of $149.3 million for the second quarter of 2026, a 10.2% year-over-year increase in constant currencies, and raised its full-year revenue growth outlook to 8-10%. Gross margin expanded 200 basis points to 46.8%, while adjusted earnings per share of $0.60 marked the highest since the third quarter of 2020, up 45% from a year earlier. Injection molding revenue accelerated 12.9% and CNC machining revenue grew 13.1%, both driven by strength in aerospace and defense, which now accounts for 25% of total revenue. 3D printing revenue declined 2.7% year-over-year, and network revenue was flat, while factory revenue grew 14%. The company generated $15.4 million in cash from operations and held $62.9 million in cash and investments with no debt.

Proto Labs is back in focus after expanding its manufacturing support for drone manufacturers, adding tighter tolerance quick-turn CNC machining and advanced 3D printing as demand in the drone sector continues to build. The stock last closed at $74.40, while the most followed narrative points to a fair value of about $75.67, leaving a modest 2% gap. The company has seen a 90-day share price return of 21.17% and a year-to-date return of 44.89%, with a one-year total shareholder return of 85.35%. Ongoing investments in sales enablement and marketing have driven an 11% year-over-year increase in revenue per customer and a 44% rise in cross-platform adoption. However, investors must weigh risks including reliance on large Aerospace & Defense accounts and pressure in legacy prototyping and injection molding, while the current P/E ratio of 68.7x sits well above the US Machinery industry average of 26.5x.

Protolabs has expanded its manufacturing capabilities to support drone manufacturers amid rapid industry growth. The company's drone customer revenue has grown more than 90% since 2023 with a compound annual growth rate of nearly 40%. Expanded capabilities include quick-turn CNC machining for end-use metal and plastic parts with tighter tolerances and greater precision, as well as advanced Multi Jet Fusion 3D printing through a partnership with HP Additive tailored to drone manufacturing. The global drone industry is currently valued at up to $69 billion and is expected to reach $140 billion within the next decade. Protolabs will showcase its drone manufacturing capabilities at the Commercial UAV Expo in Las Vegas from September 1 to 3.

Enovis, Insteel Industries, Mueller Water Products, and Proto Labs are highlighted as growth stocks trading under $100 with strong long-term potential. Enovis saw 11% reconstructive sales growth in Q1 2026 and holds a Strong Buy consensus with a $42 average price target, roughly 91% above its current $22. Insteel Industries reported Q2 sales up 7.5% year over year, driven by infrastructure spending and record data center construction permits. Mueller Water Products posted Q2 net sales up 4.6% and benefits from $55 billion in federal water infrastructure funding. Proto Labs is pivoting from prototyping to production-grade manufacturing, with a $1.2 billion market cap and shares at $80.

Zacks Investment Research identifies DuPont de Nemours, Proto Labs, AMETEK, and ATI as compelling 3D printing stocks for long-term returns. DuPont strengthened its medical additive manufacturing capabilities through the 2023 acquisition of Spectrum Plastics Group, which uses proprietary processes like Projection Micro Stereolithography and Silicone 3D Printing. Proto Labs, which has manufactured over 700 million parts for more than 300,000 customers, launched an AI-enabled manufacturing platform called ProDesk in February 2026 to accelerate prototyping and production. AMETEK produces high-performance metal powders for additive manufacturing and expanded its precision scanning portfolio with the July 2025 acquisition of Faro Technologies. ATI offers end-to-end additive manufacturing capabilities from metal powder to finished parts and recently commissioned a state-of-the-art facility combining design, printing, heat treating, machining, and inspection for aerospace, defense, and space applications.